MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.amjms.2024.07.016

Медицинская библиотека · The American journal of the medical sciences · 2024

Meta-analysis of renin angiotensin aldosterone modulators mitigating atrial fibrillation risk in hypertensive patients.

Mahadevan Arankesh, Garikipati Sushmitha, Vanani Samir, Sundaram Dakshin Meenashi, Thompson-Edwards Ashley, Reyaz Nafisa, Babu Kalaivani, Rajarajan Srinishant, Dhavapalani Dhayashri, Anand Dharshana Prem, Vasavada Advait, Desai Rupak

СтатьяМетаанализПеревод в очереди

Аннотация

INTRODUCTION

Hypertension is associated with left ventricular hypertrophy/enlargement/fibrosis and atrial ectopic rhythm, leading to an increased risk of Atrial Fibrillation (AF). We aimed to stratify the effect of Angiotensin Converting Enzyme Inhibitors (ACEi) and Angiotensin Receptor Blockers (ARB) on the risk of AF.

METHODS

PubMed, Scopus, and Google Scholar databases were screened, and cross-citation was conducted for studies reporting AF in hypertensive patients on ACEi and ARB. Of 145 studies found till May 2023, 19 were included in this study. Binary random-effects models estimated the pooled odds ratios, I2 statistics assessed heterogeneity and sensitivity analysis was assessed using the leave-one-out method.

RESULTS

153,559 hypertensive patients met the inclusion criteria. For incidental AF, ACEi and ARB showed a significant decrease in both unadjusted (OR 0.75, 95% CI [0.66-0.85], I² = 20.79%, p=0.29) and adjusted risks (OR 0.76, 95% CI [0.62-0.93], I² = 88.41%, p<0.01). In recurrent AF, the unadjusted analysis showed no significant effect (OR 0.89, 95% CI [0.55-1.42], I² = 78.44%, p<0.01), while the adjusted analysis indicated a reduced risk (OR 0.62, 95% CI [0.50-0.76], I² = 65.71%, p<0.01). Leave-one-out sensitivity analysis confirmed these results.

CONCLUSIONS

ACEi and ARB considerably decrease the risk of incidental and recurrent AF in hypertensive patients, emphasizing the importance of treating clinical hypertension with these drugs.

Для цитирования: Mahadevan Arankesh, Garikipati Sushmitha, Vanani Samir, Sundaram Dakshin Meenashi, Thompson-Edwards Ashley, Reyaz Nafisa, Babu Kalaivani, Rajarajan Srinishant, Dhavapalani Dhayashri, Anand Dharshana Prem, Vasavada Advait, Desai Rupak. Meta-analysis of renin angiotensin aldosterone modulators mitigating atrial fibrillation risk in hypertensive patients.. The American journal of the medical sciences. 2024. DOI: 10.1016/j.amjms.2024.07.016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.